Signalife, Inc. is a breakthrough medical device company focused on the detection of cardiovascular disease through continuous ECG signal monitoring. Signalife is positioned to become the premier global provider of health monitoring products. Using its patented signal processing technology, Signalife designs and develops medical devices that improve the efficacy and reduce the costs of diagnostic testing and monitoring of ambulatory patients. Signalife’s revolutionary, FDA-approved, patented 12-lead electrocardiograph (ECG) monitoring system, called Fidelity 100, records high-quality ECG signals from ambulatory cardiac patients. The Fidelity 100 addresses a critical need in the $400 billion dollar cardiovascular market.